Published: December 22, 2025
Chloroform, a versatile chemical compound known scientifically as trichloromethane (CHCl₃), continues to play a role in industries ranging from pharmaceuticals to refrigerants. As we move through 2025, many professionals wonder about its market performance. Recent data indicates overall stability, but with notable regional differences.
According to Next Move Strategy Consulting, the global Chloroform Market is predicted to reach USD 6.26 billion by the end of 2025. The industry is predicted to reach USD 8.37 billion by 2030 with a CAGR of 6.0% from 2025 to 2030.
Chloroform's journey began in the medical field as a pioneering anaesthetic agent. On World Anaesthesia Day, it is worth reflecting on landmark trials that shaped modern medicine.
In the late 19th century, under the patronage of the Sixth Nizam, Mir Mahboob Ali Khan, British surgeon Dr. Edward Lawrie conducted extensive chloroform trials in Hyderabad. These efforts, through the First and Second Hyderabad Chloroform Commissions (1888–1889), involved experiments on thousands of patients and hundreds of animals. The commissions proved that chloroform was safe when administered with careful monitoring of respiration, resolving global debates about its risks compared to alternatives like ether.
The trials' findings, published worldwide, advanced anaesthesia as a scientific discipline and influenced safe surgical practices still in use today.
In late October 2025, global chloroform prices remained stable overall, following earlier declines. Key regions showed varied performance:
United States, South Korea, and Europe: Prices stayed flat, supported by steady production rates, sufficient inventory stocks, and normal trading activities.
China: Experienced a 2.58% price decline, driven by weak downstream demand.
This stability in major markets reflects neutral industry sentiment and limited opportunities for arbitrage.
Alfa Chemistry
AquaPhoenix Scientific
Honeywell Riedel-de Haën
Occidental Petroleum Corporation
Shin-Etsu Chemical Co., Ltd.
Olin Chlorinated Organics
Yuanlong Chemical
Spectrum Chemical Mfg. Corp.
Muby Chemicals
CDH Fine Chemicals
Rocky Mountain Reagents
Sultan Healthcare
Science Company
blau chemie Holger Brügmann e.K.
Demand-side factors play a critical role in the observed trends. In China, the pharmaceutical and refrigerant sectors showed weakness. Specifically:
High domestic production reduced the need for imports.
Declining demand for refrigerant R22 occurred after the end of the hot weather season.
In contrast, the United States, South Korea, and Europe benefited from balanced supply chains and consistent operational performance at production plants.
As a market research firm, Next Move Strategy Consulting observes that this late October 2025 stability signals resilience in core markets amid seasonal shifts. However, the 2.58% drop in China highlights vulnerability in refrigerant applications, potentially pressuring pharmaceutical suppliers if demand does not rebound. This regional divergence could influence global supply allocations in the coming months, emphasizing the need for diversified sourcing strategies in the chloroform market.
The reported stability into November 2025 suggests a cautiously optimistic environment. Softness in China may persist if pharmaceutical and refrigerant demand remains subdued, while flat prices elsewhere indicate sustained balance.
At Next Move Strategy Consulting, we view these developments as indicative of a maturing market where historical medical applications intersect with industrial uses. The enduring legacy from 19th-century trials reminds stakeholders of chloroform's pharmaceutical importance, even as modern regulations and alternatives evolve.
To stay ahead in this dynamic landscape, consider these actionable takeaways:
Monitor Regional Variations Closely: Track price movements in China versus Western markets to anticipate supply chain adjustments.
Assess Pharmaceutical Demand Drivers: Evaluate potential rebounds in medical and lab applications, building on chloroform's historical anaesthetic role.
Diversify Sourcing Strategies: Reduce reliance on single regions by exploring balanced inventories amid stable Western production.
Stay Informed on Seasonal Impacts: Prepare for fluctuations in refrigerant-related demand tied to weather cycles.
Consult Specialized Research: Engage with firms like Next Move Strategy Consulting for tailored insights into chemical market trends.
By implementing these steps, industry professionals can position themselves advantageously in the chloroform market.
Debashree Dey is a senior content writer and communications specialist known for crafting audience-focused narratives and insight-driven content strategies. As a published manuscript author, she combines creative storytelling with strategic thinking to strengthen brand messaging, enhance visibility, and drive meaningful audience engagement across digital platforms. With a collaborative leadership approach, she contributes to high-impact communication initiatives that ensure consistency, clarity, and long-term brand value. Outside of work, she finds inspiration in creative projects, design exploration, and storytelling-driven ideas.
This website uses cookies to ensure you get the best experience on our website. Learn more
✖
Add Comment